Core Alternative Capital Organon & Co. Transaction History

Core Alternative Capital

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$30.45 - $39.36 $2,588 - $3,345	-85 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$28.67 - $37.13 $774 - $1,002	27 Added 46.55%	85 $3,000
Q3 2021 Nov 05, 2021	SELL	$28.63 - $35.64 $629 - $784	-22 Reduced 27.5%	58 $2,000
Q2 2021 Aug 05, 2021	BUY	$28.45 - $38.0 $2,276 - $3,040	80 New	80 $2,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

Stay updated on Core Alternative Capital with notifications on news.